Genome Biology (Nov 2018)

CRISPR/Cas9 offers a new tool for studying the role of chromatin architecture in disease pathogenesis

  • Xiang Guo,
  • Ann Dean

DOI
https://doi.org/10.1186/s13059-018-1569-z
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 3

Abstract

Read online

Abstract A recent study used CRISPR/Cas9 to reveal long-range looping between disease-related genes and their regulatory elements that is mediated by the CCCTC-binding factor (CTCF) in prostate cancer.